Showing 6,021 - 6,040 results of 44,759 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.83s Refine Results
  1. 6021
  2. 6022
  3. 6023
  4. 6024
  5. 6025
  6. 6026
  7. 6027
  8. 6028

    Image2_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF by Qiao Liu (346535)

    Published 2021
    “…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
  9. 6029

    Image1_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIFF by Qiao Liu (346535)

    Published 2021
    “…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
  10. 6030

    Image3_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF by Qiao Liu (346535)

    Published 2021
    “…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
  11. 6031

    Peak abundances for the N-glycans which had the obvious overall changes among control subjects, moderate and severe LCMM subjects. by Jie Chen (5892)

    Published 2015
    “…<p>Peak3, Peak4 and Peak6 decreased, whereas Peak5 increased associated with the severity of LCMM disease. …”
  12. 6032
  13. 6033
  14. 6034
  15. 6035
  16. 6036
  17. 6037
  18. 6038
  19. 6039

    A 60-year-old male with a hyperacute cardioembolic infarction fifteen hours after the onset. by Daichi Momosaka (6160418)

    Published 2020
    “…<b>G:</b> MTR<sub>asym</sub> spectra show decreased MTR<sub>asym</sub> (3.5ppm) or APTW signal (%) in the infarct area compared to the CNAWM. mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FLAIR, fluid attenuated inversion recovery; DWI, diffusion-weighted imaging; ROI, region-of-interest; ADC, apparent diffusion coefficient; APTW, amide proton transfer-weighted; CEST, chemical exchange saturation transfer; CNAWM, contralateral normal-appearing white matter; S<sub>sat</sub>(ppm) and S0, the signal intensities obtained with and without selective radiofrequency saturation pulse irradiation, respectively; APT<sub>10</sub>, APT<sub>25</sub>, APT<sub>50</sub>, APT<sub>75</sub>, and APT<sub>90</sub> correspond to the 10th, 25th, 50th, 75th, and 90th percentiles of the APTW signal value within the ROI, respectively.…”
  20. 6040

    A 59-year-old male with a subacute atherosclerotic infarction nine days after the onset. by Daichi Momosaka (6160418)

    Published 2020
    “…<b>G:</b> MTR<sub>asym</sub> spectra show decreased MTR<sub>asym</sub>(3.5ppm) or APTW signal (%) in the infarct area compared to the CNAWM. mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; FLAIR, fluid attenuated inversion recovery; DWI, diffusion-weighted imaging; ROI, region-of-interest; ADC, apparent diffusion coefficient; APTW, amide proton transfer-weighted; CEST, chemical exchange saturation transfer; CNAWM, contralateral normal-appearing white matter; S<sub>sat</sub> (ppm) and S<sub>0</sub>, the signal intensities obtained with and without selective radiofrequency saturation pulse irradiation, respectively; APT<sub>10</sub>, APT<sub>25</sub>, APT<sub>50</sub>, APT<sub>75</sub>, and APT<sub>90</sub>, correspond to the 10th, 25th, 50th, 75th, and 90th percentiles of APTW signal value, respectively.…”